These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 991466)

  • 21. Nephropathy induced by D-penicillamine.
    Lange K
    Contrib Nephrol; 1978; 10():63-74. PubMed ID: 97051
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathohistologic and ultrastructural features of drug-induced membranous glomerulonephritis].
    Pospishil' IuA
    Arkh Patol; 1996; 58(5):52-6. PubMed ID: 9005826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic immune complex glomerulonephritis in dogs with multisystem involvement.
    Jeraj KP; Vernier RL; Polzin D; Klausner JK; Osborne CA; Stevens JB; Michael AF
    Am J Vet Res; 1984 Sep; 45(9):1699-705. PubMed ID: 6238560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proteinuria and nephrotic syndrome in penicillamine therapy. Reversibility of immunopathologic findings in animal experiments].
    Seelig HP; Seelig R
    Dtsch Med Wochenschr; 1977 Jul; 102(28):1035-6. PubMed ID: 891372
    [No Abstract]   [Full Text] [Related]  

  • 31. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.
    Levidiotis V; Freeman C; Punler M; Martinello P; Creese B; Ferro V; van der Vlag J; Berden JH; Parish CR; Power DA
    J Am Soc Nephrol; 2004 Nov; 15(11):2882-92. PubMed ID: 15504941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extracapillary glomerulonephritis secondary to D-penicillamine. Apropos of 1 case and review of the literature].
    Marchand-Courville S; Dhib M; Fillastre JP; Godin M
    Nephrologie; 1998; 19(1):25-32. PubMed ID: 9551449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protamine sulphate-induced proteinuria: the roles of glomerular injury and depletion of polyanion.
    Messina A; Davies DJ; Ryan GB
    J Pathol; 1989 Jun; 158(2):147-56. PubMed ID: 2754545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotic-range proteinuria with small glomerular fibrillary deposits in a patient on diphenylhydantoin treatment.
    Kiykim AA; Genctoy G; Horoz M; Sari S; Gok E; Coskun B; Yilmaz N; Gurses I
    Med Sci Monit; 2009 Aug; 15(8):CS132-4. PubMed ID: 19644425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [D-penicillamine and glomerulonephritis].
    Altrogge G; Hofmann K; Huth F; Grabensee B; Schoppe WD
    Med Welt; 1976 Nov; 27(47):2282-3. PubMed ID: 1004174
    [No Abstract]   [Full Text] [Related]  

  • 40. Production of autologous immune complex glomerulonephritis in rats by injections of heterologous renal tubular antigen.
    Nagi AH; Barabas AZ; Alexander F; Lannigan R
    Acta Med Acad Sci Hung; 1971; 28(3):249-57. PubMed ID: 4262490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.